RANDAL S WEBER to Radiation-Sensitizing Agents
This is a "connection" page, showing publications RANDAL S WEBER has written about Radiation-Sensitizing Agents.
Connection Strength
0.196
-
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys. 2008 Aug 01; 71(5):1351-5.
Score: 0.069
-
A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer. Int J Radiat Oncol Biol Phys. 1999 May 01; 44(2):311-5.
Score: 0.036
-
Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers. Semin Radiat Oncol. 1999 Apr; 9(2 Suppl 1):97-101.
Score: 0.036
-
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes. J Clin Oncol. 2015 Oct 10; 33(29):3262-8.
Score: 0.028
-
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol. 2014 Sep 20; 32(27):2940-50.
Score: 0.026